- Home
- ARWR vs EQC Comparison
ARWR vs EQC Comparison
Compare ARWR & EQC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARWR
- EQC
- Stock Information
- Founded
- ARWR 2003
- EQC 1986
- Country
- ARWR United States
- EQC United States
- Employees
- ARWR N/A
- EQC N/A
- Industry
- ARWR Biotechnology: Pharmaceutical Preparations
- EQC Real Estate Investment Trusts
- Sector
- ARWR Health Care
- EQC Real Estate
- Exchange
- ARWR Nasdaq
- EQC Nasdaq
- Market Cap
- ARWR 1.7B
- EQC 174.6M
- IPO Year
- ARWR 1993
- EQC 1986
- Fundamental
- Price
- ARWR $11.24
- EQC $1.59
- Analyst Decision
- ARWR Buy
- EQC
- Analyst Count
- ARWR 11
- EQC 0
- Target Price
- ARWR $41.44
- EQC N/A
- AVG Volume (30 Days)
- ARWR 2.2M
- EQC 1.6M
- Earning Date
- ARWR 05-08-2025
- EQC 04-30-2025
- Dividend Yield
- ARWR N/A
- EQC N/A
- EPS Growth
- ARWR N/A
- EQC N/A
- EPS
- ARWR N/A
- EQC 0.26
- Revenue
- ARWR $2,500,000.00
- EQC $57,570,000.00
- Revenue This Year
- ARWR $4,380.43
- EQC N/A
- Revenue Next Year
- ARWR $64.24
- EQC N/A
- P/E Ratio
- ARWR N/A
- EQC $6.02
- Revenue Growth
- ARWR N/A
- EQC N/A
- 52 Week Low
- ARWR $9.57
- EQC $1.40
- 52 Week High
- ARWR $30.41
- EQC $21.00
- Technical
- Relative Strength Index (RSI)
- ARWR 38.40
- EQC 37.20
- Support Level
- ARWR $9.64
- EQC $1.58
- Resistance Level
- ARWR $12.93
- EQC $1.63
- Average True Range (ATR)
- ARWR 1.18
- EQC 0.02
- MACD
- ARWR 0.18
- EQC 0.01
- Stochastic Oscillator
- ARWR 43.21
- EQC 20.00
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.
About EQC Equity Commonwealth of Beneficial Interest
Equity Commonwealth is a real estate investment trust engaged in the acquisition, ownership, and operation of office buildings located throughout the United States. The vast majority of the company's real estate portfolio comprises office assets. These properties are fairly evenly dispersed between many of America's urban markets, notably Washington, Austin and Denver. Equity Commonwealth derives the vast majority of its income in the form of rental revenue from tenants occupying its offices.